Financials
Value Q1, 25Q2, 25Q3, 25 TTM Selling/general/admin expenses —6.49 M8.87 M — Research & development ——— — Operating income -16.1 K-34.38 M-8.62 M — Non-Operating Income, Total 10 K144.65 M-3.89 M — Interest expense, net of interest capitalized ——— — Non-Operating Income, excl. Interest Expenses 10 K144.91 M-3.34 M — Unusual income/expense —-260.73 K-551.55 K — Pretax income -6 100110.27 M-12.51 M — Equity in earnings ——— — Taxes 0—— — Non-controlling/minority interest ——— — After tax other income/expense ——— — Net income before discontinued operations -6 100-1.22 M-12.51 M — Discontinued operations ——— — Net income -6 100-1.22 M-12.51 M — Dilution adjustment ——— — Preferred dividends ——— — Diluted net income available to common stockholders -6 100-1.22 M-12.51 M — Basic earnings per share (Basic EPS) -610.83-0.08 — Diluted earnings per share (Diluted EPS) -610.83-0.08 — Average basic shares outstanding 100133.64 M149.53 M — Diluted shares outstanding 100133.64 M149.53 M — EBITDA ——— — EBIT —-30.49 M-13.51 M — Cost of revenue —1.85 M6.21 M — Other cost of goods sold ——— — Depreciation & amortization (cash flow) ——— —